Interaction Color Code
Clinical Bottom Line
Do not coadminister: Reduced levels of velpatasvir and voxilapervir
Drug 1
Drug 2 effect
Velpatasvir Cmax decreased 37%; AUC decreased 43%; Cmin decreased 47%
Clinical Effects
Reduced levels of velapatasvir and voxilaprevir
Management
Contraindicated. Use alternative agents.
Import ID
465
